----

----

| Delaware                                                           |   | 26-2940963                           |
|--------------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization)     |   | (I.R.S. Employer Identification No.) |
|                                                               |   |                                 |
| 10005 Muirlands Blvd Suite G, Irvine, California                   |   | 92618                                |
| (Address of Principal Executive Offices)                           |   | (Zip Code)                           |
|                                                               |   |                                 |
| Registrant's telephone number, including area code: (949)-419-0288 |

| Large accelerated filer | o | Accelerated filer         | o |
|-------------------------|---|---------------------------|---|
| Non-accelerated filer   | o | Smaller reporting company | x |

----

----

----

----

| 10.1 |   | Amendment dated June 3, 2011 to Patent License Agreement, dated March 25, 2010 between the University of Mississippi and the Company. *‡                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.1 |   | Certification of the Chief Executive Officer pursuant to §240.13a−14 or §240.15d−14 of the Securities Exchange Act of 1934, as amended †‡                                                                                                                                                                                                                                                                                                                                                                                                          |
| 31.2 |   | Certification of the Chief Financial Officer pursuant to §240.13a−14 or §240.15d−14 of the Securities Exchange Act of 1934, as amended †‡                                                                                                                                                                                                                                                                                                                                                                                                          |
| 32.1 |   | Certification pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes−Oxley Act of 2002) †‡                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 101  |   | The following financial information from the Company’s Quarterly Report on Form 10-Q for the quarter ended July 2, 2011, filed with the Securities and Exchange Commission on August 11, 2011, formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Cash Flows, (iv) the Condensed Consolidated Statements of Stockholders’ Equity, (v) the Notes to Condensed Consolidated Financial Statements. † |

----

|                                                                                                |   | ChromaDex Corporation                               |
|-----------------------------------------------------------------------------------------------------|--------|-----------------------------------------------------|
|                                                                                                |   | (Registrant)                                        |
| Date:           October 12, 2011   |   |                                                |
|                                                                                                |   | /s/ THOMAS C. VARVARO                               |
|                                                                                                |   | Thomas C. Varvaro                                   |
|                                                                                                |   | Duly Authorized Officer and Chief Financial Officer |